Why is Pfizer sharing its COVID-19 pill but not its vaccine?

Pfizer’s chief executive Albert Bourla says his COVID-19 oral antiviral drug is “a real game changer”. He claims the pill cuts the risk of hospitalisation and death by 89 percent.

But unsurprisingly campaigners are already raising concerns that the rich world will once again corner the anti-viral market. Dr Githinji Gitahi, the chief executive of Amref Health Africa, explains what needs to be done for the equitable distribution of vaccines.

And Willie Walsh, the director general of the International Air Transport Association, tells us when the industry will recover from the pandemic.